Effect of heptavalent pneumococcal conjugate vaccination on invasive pneumococcal disease in preterm born infants
<p>Abstract</p> <p>Background</p> <p>Evidence for protection of preterm born infants from invasive pneumococcal disease (IPD) by 7-valent pneumococcal conjugate vaccination (PCV7) is relatively sparse. Data from randomized trials is based on relatively small numbers of...
Main Authors: | von Kries Rüdiger, van der Linden Mark, Rückinger Simon |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-01-01
|
Series: | BMC Infectious Diseases |
Online Access: | http://www.biomedcentral.com/1471-2334/10/12 |
Similar Items
-
Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease
by: Edmunds W John, et al.
Published: (2010-04-01) -
Antimicrobial resistance among isolates causing invasive pneumococcal disease before and after licensure of heptavalent conjugate pneumococcal vaccine.
by: Tom Theodore Karnezis, et al.
Published: (2009-01-01) -
Safety and Immunogenicity of Heptavalent Pneumococcal Conjugate Vaccine Booster in Taiwanese Toddlers
by: Pei-Lan Shao, et al.
Published: (2006-01-01) -
Effects of Infant Pneumococcal Conjugate Vaccination on Serotype Distribution in Invasive Pneumococcal Disease among Children and Adults in Germany.
by: Mark van der Linden, et al.
Published: (2015-01-01) -
Impact on respiratory tract infections of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months of age
by: Cesati Laura, et al.
Published: (2007-02-01)